Cellerant Therapeutics, Inc. STTR Phase II Award, January 2018
A STTR Phase II contract was awarded to Cellerant Therapeutics in January, 2018 for $1,117,159.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Currently, there are no issues on this topic.
Find more entities like Cellerant Therapeutics, Inc. STTR Phase II Award, January 2018
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.